Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
$4.70
$0.00
$0.00
$0.00
$8.51M-0.1287,171 shs370,983 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$178.13
+7.0%
$174.95
$137.71
$182.38
$18.58B0.491.01 million shs2.70 million shs
DaVita Inc. stock logo
DVA
DaVita
$146.09
+4.8%
$140.11
$131.76
$179.60
$11.03B1.11810,769 shs970,731 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$252.34
+3.8%
$253.65
$205.98
$265.72
$21.12B0.82654,512 shs1.01 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
0.00%0.00%0.00%0.00%0.00%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
+0.08%-0.83%-6.90%-3.26%+14.33%
DaVita Inc. stock logo
DVA
DaVita
-1.19%-2.77%+2.04%+3.33%+1.09%
Labcorp Holdings Inc. stock logo
LH
Labcorp
-0.37%-2.78%-7.33%+10.21%+14.88%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.869 of 5 stars
2.32.04.24.73.82.52.5
DaVita Inc. stock logo
DVA
DaVita
4.3565 of 5 stars
2.02.00.04.52.31.73.8
Labcorp Holdings Inc. stock logo
LH
Labcorp
4.3421 of 5 stars
2.32.02.54.23.22.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
0.00
N/AN/AN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.69
Moderate Buy$186.074.46% Upside
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$164.5012.60% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.57
Moderate Buy$276.089.41% Upside

Current Analyst Ratings Breakdown

Latest BRLI, LH, DGX, and DVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$176.00 ➝ $175.00
7/18/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$284.00 ➝ $282.00
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$260.00
7/9/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$260.00 ➝ $285.00
6/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingCautious ➝ Cautious
6/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.00
6/11/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.00
5/19/2025
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$170.00 ➝ $164.00
5/12/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$274.00 ➝ $290.00
5/6/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00
(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
N/AN/AN/AN/A($1.89) per shareN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$10.16B1.96$14.41 per share12.36$61.38 per share2.90
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.86$19.80 per share7.38$4.83 per share30.25
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.01B1.62$23.19 per share10.88$96.27 per share2.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
-$970KN/A0.00N/AN/AN/A-4.47%N/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$871M$7.9122.5216.982.338.81%15.11%6.65%7/22/2025 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.0914.4811.490.976.63%176.11%4.66%8/5/2025 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$746M$8.6529.1714.391.545.55%15.27%6.97%7/24/2025 (Estimated)

Latest BRLI, LH, DGX, and DVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
DaVita Inc. stock logo
DVA
DaVita
$2.70N/AN/AN/A$3.36 billionN/A
7/24/2025Q2 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.12N/AN/AN/A$3.49 billionN/A
7/22/2025Q2 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billion
5/12/2025Q1 2025
DaVita Inc. stock logo
DVA
DaVita
$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion
4/29/2025Q1 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion
4/22/2025Q1 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
N/AN/AN/AN/AN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.201.80%N/A40.46%14 Years
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.881.14%N/A33.29%N/A

Latest BRLI, LH, DGX, and DVA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.11%8/28/20259/11/2025
5/14/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.801.86%7/7/20257/7/20257/21/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
N/A
0.99
0.99
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.84
1.44
1.31
DaVita Inc. stock logo
DVA
DaVita
23.18
1.25
1.20
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.68
1.84
1.60

Institutional Ownership

CompanyInstitutional Ownership
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
11.82%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
DaVita Inc. stock logo
DVA
DaVita
90.12%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%

Insider Ownership

CompanyInsider Ownership
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
69.80%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
8.16%
DaVita Inc. stock logo
DVA
DaVita
2.00%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brilliant Acquisition Co. stock logo
BRLI
Brilliant Acquisition
N/A1.81 million548,000Not Optionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
56,000111.64 million102.53 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
76,00075.50 million73.99 millionOptionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
70,00083.70 million83.00 millionOptionable

Recent News About These Companies

Labcorp (NYSE:LH) Given New $282.00 Price Target at UBS Group
UBS Group Lowers Labcorp (NYSE:LH) Price Target to $282.00
My Favorite Options Trade For This Week
Labcorp (LH) to Release Earnings on Thursday
Labcorp (NYSE:LH) Downgraded to Hold Rating by Hsbc Global Res

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Brilliant Acquisition stock logo

Brilliant Acquisition NASDAQ:BRLI

Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$178.13 +11.68 (+7.02%)
Closing price 03:58 PM Eastern
Extended Trading
$173.63 -4.50 (-2.53%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

DaVita stock logo

DaVita NYSE:DVA

$146.09 +6.66 (+4.78%)
Closing price 03:58 PM Eastern
Extended Trading
$146.66 +0.57 (+0.39%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Labcorp stock logo

Labcorp NYSE:LH

$252.34 +9.30 (+3.82%)
Closing price 03:58 PM Eastern
Extended Trading
$251.82 -0.52 (-0.20%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.